Lakeshore partners with companies that operate at the intersection of national interest, industrial capability, and private capital. We work alongside founders, management teams, shareholders, and financial sponsors to address complex situations across geographies and business models, supporting companies as they scale through pivotal moments in their lifecycle.
Our focus is on industries of strategic consequence: maritime and aerospace autonomy, and the critical medicines that hold societies together. These are domains where commercial trajectory and strategic weight are inseparable, and where flexible, long-horizon capital is often the difference between potential and outcome.
Pre-seed to Series A venture capital backing technical founders with deep operating experience in the platforms, components, and capabilities upon which allied industrial sovereignty will depend.
We partner with growth-stage companies across our domains, taking qualified minority to majority control positions in businesses headquartered in DACH and select Western European and global markets.
As a special opportunity middle-market investor, we help fund companies’ capital needs with flexible structures that span a range of unique situations, geographies, and business models. For these transactions, we collaborate closely with management teams, shareholders, and financial sponsors alike, structuring ourselves around the work the company actually requires rather than the constraints of a standard playbook.
Unmanned surface and subsurface platforms, sensing, and the industrial supply chains of allied seapower.
Uncrewed aerial platforms, propulsion, and the dual-use technologies redefining airspace and orbit.
Research, development, and manufacturing of critical medicines that form the foundations of demographic resilience and the industrial base of allied healthcare.
Early-stage operators developing platforms in maritime autonomy, aerospace autonomy, and critical-medicines manufacturing. We back conviction technical teams from pre-seed through Series A.
Reach out to venturesProfitable, growing companies in our verticals seeking patient ownership, strategic capital, or succession-aligned partners. Control and significant minority positions across growth and buyout.
Reach out to private equity